Guidance on an additional dose of COVID-19 vaccines in the spring of 2024 for individuals at high risk of severe illness due to COVID-19

January 17, 2024 – On January 12, 2024, the Public Health Agency of Canada (PHAC) released the National Advisory Committee on Immunization’s (NACI) Guidance on an additional dose of COVID-19 vaccines in the spring of 2024 for individuals at high risk of severe illness due to COVID-19. This guidance is based on current evidence and NACI expert opinion.

For more information please visit https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-guidance-additional-dose-covid-19-vaccines-spring-2024-individuals-high-risk-severe-illness-due-covid-19.html

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Scientists say they have identified a root cause of lupus — one that could pave the way for new treatments

Read

Belimumab (Benlysta) Now Approved in Saskatchewan, Nova Scotia, and New Brunswick for Lupus Nephritis

Read

LIVING WITH LUPUS | Elizabeth L.

Read